tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

ACADIA Pharmaceuticals Inc

ACAD
Add to Watchlist
25.870USD
-0.680-2.56%
Close 07-31 16:00（ET）Quotes delayed by 15 min
4.43BMarket Cap
11.60P/E TTM

ACADIA Pharmaceuticals Inc

25.870
-0.680-2.56%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

ACAD Financials

See ACADIA Pharmaceuticals Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

ACADIA Pharmaceuticals Inc Earnings Date

Latest Release
Aug 4, 2026
EPS / Forecast
--/0.06
Revenue / Forecast
--/295.86M
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
1.07B
11.87%
EPS(YoY)
2.32
69.96%
Analyst Rating
BUY
2026/08/01
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
-81.26%0.02
86.54%1.61
115.36%0.43
-21.22%0.16
13.31%0.11
210.62%0.86
149.74%0.20
2857.18%0.20
137.89%0.10
207.88%0.28
---0.40
--0.01
---0.27
---0.26
---1.08
----
----
----
----
----
Revenue
9.72%268.06M
9.39%283.99M
11.27%278.63M
9.34%264.57M
18.70%244.32M
12.36%259.60M
18.28%250.40M
46.44%241.96M
73.75%205.83M
69.27%231.04M
61.96%211.70M
22.79%165.24M
2.59%118.46M
4.38%136.49M
-0.68%130.71M
16.79%134.56M
8.37%115.47M
8.06%130.76M
9.15%131.61M
4.65%115.22M
Net Profit
-80.84%3.64M
90.32%273.57M
119.07%71.78M
-20.14%26.67M
14.69%18.99M
213.87%143.74M
150.27%32.77M
2897.22%33.39M
138.48%16.55M
209.76%45.80M
-139.77%-65.18M
103.28%1.11M
61.95%-43.02M
3.18%-41.73M
-88.03%-27.18M
22.47%-34.01M
-70.14%-113.06M
35.45%-43.09M
82.92%-14.46M
-4.11%-43.87M
Net Margin
-82.54%1.36%
73.98%96.33%
96.88%25.76%
-26.96%10.08%
-3.38%7.77%
179.34%55.37%
142.50%13.09%
1946.79%13.80%
122.15%8.04%
164.84%19.82%
---30.79%
--0.67%
---36.32%
---30.57%
---45.77%
----
----
----
----
----
Gross Margin
-0.98%90.75%
-0.91%90.77%
-0.26%92.23%
-0.33%92.16%
3.16%91.65%
-0.71%91.60%
-0.67%92.47%
-3.16%92.47%
-9.88%88.85%
-6.08%92.26%
--93.09%
--95.49%
--98.59%
--98.23%
--97.96%
----
----
----
----
----
Income Statement
Revenue
9.72%268.06M
9.39%283.99M
11.27%278.63M
9.34%264.57M
18.70%244.32M
12.36%259.60M
18.28%250.40M
46.44%241.96M
73.75%205.83M
69.27%231.04M
61.96%211.70M
22.79%165.24M
2.59%118.46M
4.38%136.49M
-0.68%130.71M
16.79%134.56M
8.37%115.47M
8.06%130.76M
9.15%131.61M
4.65%115.22M
Operating profit
-123.93%-4.62M
148.87%17.39M
12.99%35.76M
6.36%32.37M
26.82%19.29M
-80.00%6.99M
154.77%31.64M
902.21%30.44M
128.39%15.21M
175.86%34.94M
-87.18%-57.78M
109.02%3.04M
52.59%-53.58M
-3.15%-46.06M
-101.73%-30.87M
23.01%-33.65M
-69.26%-113.02M
33.51%-44.66M
82.19%-15.30M
0.68%-43.71M
Net Profit
-80.84%3.64M
90.32%273.57M
119.07%71.78M
-20.14%26.67M
14.69%18.99M
213.87%143.74M
150.27%32.77M
2897.22%33.39M
138.48%16.55M
209.76%45.80M
-139.77%-65.18M
103.28%1.11M
61.95%-43.02M
3.18%-41.73M
-88.03%-27.18M
22.47%-34.01M
-70.14%-113.06M
35.45%-43.09M
82.92%-14.46M
-4.11%-43.87M
Balance Sheet
Current assets
25.84%1.10B
13.19%1.06B
36.55%1.08B
31.78%960.55M
28.97%870.94M
52.29%938.32M
57.92%788.28M
47.96%728.92M
34.29%675.30M
21.30%616.13M
-4.29%499.17M
-7.49%492.63M
-7.26%502.85M
-17.79%507.94M
-18.62%521.55M
-17.53%532.52M
-19.55%542.22M
-13.91%617.82M
-12.23%640.92M
-12.23%645.73M
Total current liabilities
0.99%305.52M
-29.82%277.11M
3.67%356.58M
-2.32%330.02M
-8.49%302.53M
55.31%394.87M
64.09%343.94M
79.76%337.85M
47.39%330.60M
102.38%254.25M
79.81%209.60M
59.70%187.94M
87.54%224.30M
30.77%125.63M
32.14%116.57M
23.45%117.68M
9.35%119.60M
-9.34%96.07M
-3.96%88.22M
10.31%95.33M
Total assets
41.76%1.61B
31.69%1.56B
36.23%1.33B
34.07%1.23B
32.42%1.13B
58.59%1.19B
54.44%976.87M
42.21%914.10M
30.49%855.10M
27.41%748.96M
4.99%632.54M
4.90%642.77M
4.97%655.30M
-16.04%587.81M
-16.05%602.49M
-15.41%612.77M
-17.34%624.25M
-10.54%700.12M
-9.80%717.67M
-4.64%724.43M
Total liabilities
-2.71%357.16M
-25.97%336.81M
3.46%413.50M
1.45%403.17M
-6.12%367.13M
43.43%454.96M
47.83%399.69M
60.91%397.40M
39.14%391.06M
69.27%317.20M
52.92%270.37M
38.81%246.98M
56.61%281.05M
17.69%187.40M
17.31%176.81M
11.48%177.92M
3.39%179.45M
2.33%159.23M
7.05%150.72M
65.15%159.59M
Total equity
63.10%1.25B
67.49%1.23B
58.92%917.27M
59.16%822.38M
64.91%765.24M
69.72%732.79M
59.37%577.18M
30.55%516.70M
23.99%464.04M
7.83%431.75M
-14.92%362.17M
-8.98%395.79M
-15.86%374.26M
-25.97%400.41M
-24.92%425.69M
-23.01%434.85M
-23.52%444.80M
-13.73%540.89M
-13.42%566.96M
-14.81%564.84M
Cash Flow Statement
Net operating income
67.20%33.98M
-220.68%-48.73M
17.46%74.29M
155.69%63.96M
-30.11%20.32M
-52.71%40.38M
207.28%63.25M
205.00%25.01M
262.15%29.08M
457.97%85.39M
-8009.35%-58.95M
162.48%8.20M
76.51%-17.93M
-3.17%-23.85M
95.74%-727.00K
48.18%-13.13M
-26.90%-76.33M
15.89%-23.12M
25.13%-17.06M
31.33%-25.33M
Net investment
153.43%66.28M
-145.74%-55.87M
3.77%-79.35M
22.95%-43.29M
-783.60%-124.05M
35301.73%122.15M
-341.74%-82.46M
71.08%-56.19M
-107.29%-14.04M
98.04%-347.00K
120.91%34.11M
-248.20%-194.28M
46.57%192.52M
-124.81%-17.75M
109.88%15.44M
-224.27%-55.80M
325.38%131.34M
161.17%71.55M
-202.17%-156.32M
-113.56%-17.21M
Net financing
130.20%4.23M
1051.14%22.67M
3416.04%9.42M
347.57%15.96M
76.22%1.84M
-63.77%1.97M
-97.90%268.00K
-34.92%3.56M
-28.85%1.04M
236.68%5.43M
4342.86%12.75M
42.99%5.48M
-40.58%1.47M
-63.02%1.61M
-73.08%287.00K
-23.46%3.83M
-68.07%2.47M
-75.92%4.37M
-90.90%1.07M
-89.44%5.00M

FAQs

What is the total revenue of ACADIA Pharmaceuticals Inc?

According to ACADIA Pharmaceuticals Inc's FY2025 earnings report, its total revenue reached 1.07B, with a year-on-year change of 957.80M.

What are the current assets of ACADIA Pharmaceuticals Inc?

According to ACADIA Pharmaceuticals Inc's FY2025 earnings report, its current assets were 1.06B, with a year-on-year change of 13.19.

What are the total assets of ACADIA Pharmaceuticals Inc?

According to ACADIA Pharmaceuticals Inc's FY2025 earnings report, its total assets of ACADIA Pharmaceuticals Inc were 1.56B, with a year-on-year change of 31.69.

What are the total liabilities of ACADIA Pharmaceuticals Inc?

According to ACADIA Pharmaceuticals Inc's FY2025 earnings report, its total liabilities of ACADIA Pharmaceuticals Inc were 336.81M, with a year-on-year change of -25.97.

What is the total equity of ACADIA Pharmaceuticals Inc?

According to ACADIA Pharmaceuticals Inc's FY2025 earnings report, its total equity of ACADIA Pharmaceuticals Inc was 1.23B, with a year-on-year change of 67.49.

What is the net operating income of ACADIA Pharmaceuticals Inc?

According to ACADIA Pharmaceuticals Inc's FY2025 earnings report, its net operating income of ACADIA Pharmaceuticals Inc was 104.81M, with a year-on-year change of 24.36.

What is the net investment of ACADIA Pharmaceuticals Inc?

According to ACADIA Pharmaceuticals Inc's FY2025 earnings report, its net investment of ACADIA Pharmaceuticals Inc was -302.56M, with a year-on-year change of -890.78.

What is the net financing of ACADIA Pharmaceuticals Inc?

According to ACADIA Pharmaceuticals Inc's FY2025 earnings report, its net financing of ACADIA Pharmaceuticals Inc was 49.88M, with a year-on-year change of 628.75.

What is the Earnings Per Share (EPS) of ACADIA Pharmaceuticals Inc?

According to ACADIA Pharmaceuticals Inc's FY2025 earnings report, its Earnings Per Share (EPS) was 2.32, with a year-on-year change of 69.96.

What is the net income of ACADIA Pharmaceuticals Inc?

According to ACADIA Pharmaceuticals Inc's FY2025 earnings report, its net income was 391.00M, with a year-on-year change of 72.66.

What is the net margin of ACADIA Pharmaceuticals Inc?

According to ACADIA Pharmaceuticals Inc's FY2025 earnings report, its net profit margin was 36.49, with a year-on-year change of 54.34.

What is the gross margin of ACADIA Pharmaceuticals Inc?

According to ACADIA Pharmaceuticals Inc's FY2025 earnings report, its gross margin was 91.69, with a year-on-year change of 0.26.

What is the Return on Equity (ROE) of ACADIA Pharmaceuticals Inc?

According to ACADIA Pharmaceuticals Inc's FY2025 earnings report, its Return on Equity (ROE) was 39.89, with a year-on-year change of 2.58.

What is the Return on Assets (ROA) of ACADIA Pharmaceuticals Inc?

According to ACADIA Pharmaceuticals Inc's FY2025 earnings report, its Return on Assets (ROA) was 28.42, with a year-on-year change of 21.51.

What is the operating profit of ACADIA Pharmaceuticals Inc?

According to ACADIA Pharmaceuticals Inc's FY2025 earnings report, its operating profit was 104.81M, with a year-on-year change of 24.36.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy